OUR SPEAKERS

The 17th annual World Vaccine Congress and the  Immune Profiling Congress US 2017 is the place where the global vaccine industry meets to discuss commercial and scientific issues around regulation, strategy, manufacturing, clinical trials, partnering, influenza, cancer, emerging diseases and veterinary.

 

Dr Dicky Abraham, Executive Director, Project Leadership Group, Global Vaccine and Biologics Commercialization, Merck

Dr Rodolfo Alarcon, Program Officer, NIH

Dr David E. Anderson, CSO, Vbi Vaccines

Marty Anderson, Executive Director, Clinical Development - GenMed, INC Research

Marty Anderson at World Vaccine Congress Washington 2017

Bo Arve, Executive Director, Pfizer Vaccine Research

Bo Arve at World Vaccine Congress Washington 2017

Prof Laure Aurelian, Professor, University of Maryland School of Medicine

Dr Luigi Aurisicchio, Chief Executive Officer, EVVIVAX SRL

Prof Fikri Avci, Assistant Professor of Biochemistry and Molecular Biology, UGA Center for Molecular Medicine

Dr Jessica Baker Flechtner, Chief Scientific Officer, Genocea Biosciences, Inc.

Dr Ripley Ballou, VP & Head, GSK Global Vaccines US R&D Center, GSK Vaccines

Dr Ripley Ballou at World Vaccine Congress Washington 2017

Dr Roy Baynes, SVP of Head Global Clinical Development, CMO, Merck Research Laboratories (MSD)

Dr Wolfgang Bender, Chief Medical Officer, Valneva

Dr Jay A. Berzofsky, Branch Chief, Vaccine Branch, National Cancer Institute - NIH

Dr Pamuk Bilsel, Vice President Research and Development, FluGen Inc

Helene Boigard, Research Associate, Technovax

Dr James Brady, Vice President of Technical Applications and Customer Support, MaxCyte

Dr Joseph Breen, Immunoregulation Section Chief, Basic Immunology Branch, Division of Allergy, Immunology and Transplantation, NIAID, NIH, National Institute of Allergy and Infectious Diseases

Evan Brower, Senior Scientist, Principal Investigator, Paragon Bioservices

Lynlee Burton, Director of Project Delivery - Vaccines, PRA Health Sciences

Dr Danilo Casimiro, CSO, AERAS

Peter W. Che, International Business Manager, Repertoire Genesis, Inc

Dr KC Cheng, Senior Director - Analytical and Formulation Development, NIH - NIAID

Dr Roman Chicz, Associate Vice President and Global Head Of External Research and Development, Sanofi Pasteur Inc

Dr Giuseppe Ciaramella, Chief Scientific Officer, Valera LLC

Giovanni Della Cioppa, Head of R&D Center, GSK Vaccines

Dr Tim Cooke, Chief Executive Officer, NovaDigm Therapeutics

Dr Craig Curtis, Chief Medical Officer, Bioclinica Research Network

Dr Lisa Danzig, Vice President, Clinical Development and Medical Affairs, PaxVax

Prof Robert Daum, Professor of Pediatrics, The University of Chicago

Dr Annie De Groot, Chief Executive Officer, Chief Scientific Officer and Director, EpiVax Inc

Dr Annie De Groot, Chief Executive Officer, Chief Scientific Officer and Director, EpiVax Inc

Dr Michel De Wilde, Former Senior Vice President R&D of Sanofi Pasteur & Owner, MDW Consultant LLC

Giuseppe Del Giudice, Translational Science Leader, GSK Vaccines

Giuseppe Del Giudice at World Vaccine Congress Washington 2017

Dr Lelia Delamarre, Senior Scientist, Genentech

Dr Walla Dempsey, Program Officer, Clinical Research, National Institutes of Health (NIH)

Dr Francisco Diaz-Mitoma, Chief Medical Officer, VBI Vaccines Inc

Dr Donald Drake, Senior Director of Immunological Research, Sanofi Pasteur Inc

Devon DuBose, Director of Early Phase Formulation and Process Development, Capsugel

Dr Cynthia Dukes, Vice President - Global Project Management, ICON

Dr Bernard Fox, Harder Family Endowed Chair for Cancer Research Member and Chief, Lab of Molecular and Tumor Immunology & CEO of Ubivac, Oregon Health and Science University and Knight Cancer Institute

John Fraser, Dean of the Faculty of Medical and Health Sciences, University Of Auckland

Dr Patrick Frayssinet, R&D Director, URODELIA

Dr Patrick Frayssinet at World Vaccine Congress Washington 2017

Dr Leonard Friedland, VP, Scientific Affairs and Public Health Vaccines, North America, GSK

Dr Louis Fries, CMO, Novavax

Dr John Fulkerson, Vaccines and Biologics Consultant, Engility

Dr David Furman, Principal Investigator at The National Scientific and Research Council, Stanford University School of Medicine

Dr cyrilCyril G Gay, Senior National Program Leader, A.R.S. National Programs

Dr cyrilCyril G Gay at World Vaccine Congress Washington 2017

Dr Nathalie Garcon, CEO/CSO, BIOASTER

Prof Volker Gerdts, Professor of W.C.V.M. and Associate Director of Research, Vaccine and Infectious Disease Organizatio, VIDO-InterVac

Prof Volker Gerdts at World Vaccine Congress Washington 2017

Dr Jens Gertow, Scientific Advisor, Mabtech

Basav Ghosh, Sr. Director, Pfizer

Dr Renald Gilbert, Team Leader of Viral Vector Production, N.R.C. Canada

Dr Anthony Gilbert, Medical Director, hVIVO

Douglas Gladue, Senior Scientist, Plum Island Animal Disease Center, Usda

Bruno Gomes, Director, Tumor Immunology, iTeos Therapeutics

Dr Nesya Goris, Chief Development Officer & Co-Founder, ViroVet

Dr Barney Graham, Deputy Director of Vaccine Research Center, National Institute of Allergy and Infectious Diseases

Dr Luis H. Martin, Chief Executive Officer, Pan-Provincial Vaccine Enterprise Inc. (PREVENT)

Dr Luis H. Martin at World Vaccine Congress Washington 2017

Dr Emmanuel Hanon, Senior Vice President, Head of Vaccines R&D,, GSK Vaccines

Dr Ali M. Harandi, Lab head, Dpt of Microbiology & Immunology, University of Gothenburg

Dr Ali M. Harandi at World Vaccine Congress Washington 2017

Dr Audray Harris, Chief of Structural Informatics Unit Laboratory of Infectious Diseases, National Institutes of Health

Penny Heaton, Director of Vaccine Development, The Bill and Melinda Gates Foundation

Christopher Heery, Chief Medical Officer, Bavarian Nordic

Dr Thomas Heineman, Vice President of Clinical Development, Genocea Biosciences

Dr Hanjo Hennemann, Chief Scientific Officer and Co Founder, VEROVACCiNES

Dr Gray Heppner, Chief Medical Officer, New Link Genetics

Dr Alan R. Hinman, Director for Programs, Center for Vaccine Equity, Task Force for Global Health

Dr Stephen Hoffman, Chief Executive and Scientific Officer, Sanaria Inc

Dr Peter Hotez, Dean of National School of Tropical Medicine, Baylor College of Medicine & President, Sabin Vaccine Institute

Pascal Hudelet, Director of Veterinary Public Health Operations, Merial, A SANOFI Company

Dr Jeff Hutchins, Chief Scientific Officer and Senior Vice President of Preclinical Development, Heat Biologics, Inc.

Randall Hyer, VP Medical Affairs, Dynavax

Randall Hyer at World Vaccine Congress Washington 2017

Bruce Innis, Global Head of Respiratory Infections & Maternal Immunizations, PATH

Bruce Innis, Global Head of Respiratory Infections & Maternal Immunizations, PATH

Dr James Jackson, Chief Scientific Officer, Emergent BioSolutions

Dr Renaud Jacquemart, Director Vaccines Process Sciences, Natrix Separations

Dr Anass Jawhari, Chief Scientific Officer and Director of R and D, Calixar

Dr Joseph Joyce, Director, Vaccine Process Development, Merck & Co.

Dr Michael Kalos, Chief Scientific Officer, Eli Lilly and Co

Dr Howard Kaufman, Chief Surgical Officer, Assoc Director, Rutgers Cancer Institute of New Jersey

Dr Cheryl Keech, Executive Medical Director, PPD Vaccines

Chris Kemp, President, Kempbio Inc

Dr Samir Khleif, Director of Immunotherapy and Immune Oncology Program, Georgia Regents University Cancer Center

Dr Jerome Kim, Director-General, International Vaccine Institute

Dr Harry Kleanthous, Associate Vice President, Head of Research, North America, Sanofi Pasteur

Dr Wayne C Koff, President and CEO - The Human Vaccines Project, International Aids Vaccine Initative Inc

Dr Wayne C Koff at World Vaccine Congress Washington 2017

Dr Michael Kowarik, Co-Founder & Vice President Research and IP, LimmaTech Biologics AG

Prof Florian Krammer, Associate Professor, Department of Microbiology, Icahn School of Medicine at Mount Sinai

Lakshmi Krishnan, Group Leader-Senior Research Officer, National Research Council

Dr Mahesh Kumar, Vice President, Global Biologics Research, Zoetis

Dr Mahesh Kumar at World Vaccine Congress Washington 2017

Keith L Knutson, Professor of Immunology, Mayo Clinic

Nathalie Landry, Executive Vice President of Product Development, Medicago Inc

Adam Larrabee, President, Rochester Clinical Research, Inc.

Prof Bruce Levine, Professor, Perelman School of Medicine, University of Pennsylvania

Dr Myron M. Levine, Grollman Distinguished Professor and Director, Center for Vaccine Development, University of Maryland School of Medicine

Thomas Lingelbach, President and Chief Executive Officer, Valneva SE

Daniel Littlefield, Principal, Modality Solutions LLC

Dr Leslie Lobel, Senior Medical Advisor – Medical Expert Office, ClinicalRM

Dr Alfred Luitjens, Director Cell Technology at Batavia Biosciences, Batavia Biosciences

Dr Charles Lutsch, AVP R&D, Sanofi Pasteur

Dr Scott M White, Vice President - Clinical Development, Inovio Pharmaceuticals

Dr Melissa L. Madsen, Molecular Project Lead, Ceva Animal Health

Dr Kutub Mahmood, Director, PATH

Dr Richard Malley, Scientific Founder, Affinivax

Valerie Marshall, Commander, Policy Analyst, Office of Vaccines Research and CBER, Food and Drug Administration

Dr Tyler Martin, CEO, Adjuvance Technologies

Dr Laura Martin, Head of Project Portfolio, G.S.K. Vaccines Institute for Global Health

Karen McCarthy, Senior Director, Project Management, PPD Vaccines

Karen McCarthy at World Vaccine Congress Washington 2017

Dr Douglas Mcneel, Chief Scientific Founder and Head of M.V.I. Scientific Advisory Board, Madison Vaccines Inc.

Timothy Miller, CSO, Agri Laboratories Ltd

Prof James Moon, Assistant Professor of Biomedical Informatics, University of Michigan

Jeffrey Moore, President, MP Healthcare Venture

Dr Vasee Moorthy, Team Leader, Vaccine Development Initiative for Vaccine Research, Department of Immunization, Vaccines & Biologicals, World Health Organisation

Dr Sally Mossman, VP, Head Discovery Performance Unit, US, GSK Vaccines

Wilhelm (Willie) Muehlhausen, VP eCOA & Innovation, ICON Clinical Research

Wilhelm (Willie) Muehlhausen at World Vaccine Congress Washington 2017

Dr Egbert Mundt, Head of Global Poultry Vaccine R&D, Boehringer Ingelheim

Dr Gary Nabel, Chief Scientific Officer & Senior Vice President Head, North America R&D Hub, Sanofi

Stephen Nagler, Executive Director, MedPro Investors LLC

Stephen Nagler at World Vaccine Congress Washington 2017

Dr Dr. Peter Nara, President & Chief Executive Officer, Biological Mimetics

Dr Ruslan Novosiadly, Senior Research Advisor Cancer Immunobiology Biomarkers, Eli Lilly and Co

Dr Derek O'Hagan, Global Head of Vaccine Chemistry and Formulation Research, GSK Vaccines

Prof Ab Osterhaus, Director, Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover

Dr Peter Palese, PROFESSOR and CHAIR Microbiology, Mount Sinai School of Medicine

Dr Ami Patel, Senior Postdoctoral Fellow, The Wistar Institute

Dr Misha Petkevich, Chief Investment Officer, V2M Capital LLC

Dr Misha Petkevich at World Vaccine Congress Washington 2017

Prof Stanley Plotkin, Emeritus Professor, University of Pennsylvania School of Medicine

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation

Dr Steve Projan, Senior Vice President of Innovative Medicines, Research and Development and Head of Infectious Diseases and Vaccines, MedImmune Inc

Prof Bali Pulendran, Professor in the Department of Pathology and Laboratory Medicine, Emory School of Medicine & Emory Vaccine Center

Dr Mukul Ranjan, Senior Advisor for Innovation and Technology Transfer, National Institute of Allergy and Infectious Diseases N.I.H.

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines

Dr GS Reddy, Chief General Manager, Manufacturing, Indian Immunologicals Ltd

Dr Steven Reed, President and Founder, Infectious Disease Research Institute

Scott Requadt, Managing Director, Clarus Ventures

Dr Thomas Richie, Chief Medical Officer, Sanaria

Matt Roberge, Senior Director, Local Market Access & Support, Pfizer

Dr Scot Roberts, Chief Scientific Officer, Altimmune

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Sonny Saksena, Managing Director, Mahir Capital Strategies

Sonny Saksena at World Vaccine Congress Washington 2017

Dr Gautam Sanyal, Fellow, Analytical Sciences, Biopharmaceutical Development, MedImmune Inc

Dr Niranjan Sardesai, COO, Inovio

Dr Darin Seehafer, Clinical Scientist/Program Director, PRA Health Sciences

Dr Randolph Seidler, Head of Global Business Development AH, Boehringer Ingelheim Animal Health Gmbh

Dr Alessandro Sette, Professor, Head and Member, La Jolla Infectious Disease Institute

Angela Shen, CAPT, US Public Health Service, Senior Science Policy Advisor, National Vaccine Program Office, U.S. Department of Health & Human Services

Dr George Siber, CSO of ClearPath Vaccines & Scientific Advisory Board of Genocea, ClearPath Vaccines

Bruno Speder, Head of Clinical Regulatory Affairs, S.G.S. Life Science Services

Dr Yan Su, Senior Scientist, Immunomic Therapeutics

Dr Steven Swanson, Senior Vice President, Research, Immunocellular Therapeutics

Dr Jim Tartaglia, Vice President New Vaccine Project Head North America, Sanofi Pasteur

Dr Frank Tomaka, Senior Director, Clinical Lead HIV/STI Vaccines, Janssen Infectious Diseases and Vaccines

Dr Frank Tomaka at World Vaccine Congress Washington 2017

Kai Touw, Process Development Consultant, Sartorius Stedim Biotech

Dr Sean Tucker, CSO and VP Research, Vaxart

Dr Jeffrey Ulmer, Head, Preclinical R&D US, GSK Vaccines

Dr Kumaran Vadivelu, Medical Director, Global Medical Lead, Meningococcal Vaccines, GSK Vaccines

Dr Kumaran Vadivelu at World Vaccine Congress Washington 2017

Dr Michael Vajdy, Co Founder, President and Chief Scientific Officer, Epito Genesis Inc

Dr Bernard Vallat, Honorary Director General, Office International Des Epizooties

Dr Bernard Vallat at World Vaccine Congress Washington 2017

Dr Bob van Gemen, CEO, Viroclinics Biosciences B.V.

Dr Willie Vann, Chief, Laboratory of Bacterial Polysaccharides, CBER, F.D.A.

Richard Walker, Director of Enteric Vaccine Initiative, PATH

I-Ming Wang, Associate Scientific Director, Principal Scientist, Molecular Profiling Site Lead, Merck & Co.

Dr Julie Waterbury, Executive Director, Global Vaccine Strategy & Innovation, Merck & Co.

Prof David Weiner, Professor & WW Smith Chair in Cancer Research Director Wistar Vaccine Center & Executive Vice President, The Wistar Institute

Dr Jon Wigginton, Chief Medical Officer, MacroGenics

Dr Joanne Wildenbeest, Associate Professor Paediatric Infectious Diseases and Immunology, University Medical Center Utrecht

Adrian Wildfire, Project Director - Infectious Diseases & Viral Infection Unit, SGS Life Science Services

Dr Lauren V. Wood, Clinical Director and Senior Clinical Investigator, National Cancer Institute

Dr Mahesh Yadav, Research and Early Development Scientist, Genentech

Dr Mahesh Yadav at World Vaccine Congress Washington 2017

Dr Masahide Yano, Research Scientist, US Food and Drug Administration

Dr Masahide Yano at World Vaccine Congress Washington 2017

Peter Young, Executive In Residence, Pappas Capital

Dr Alan Young, CSO, Medgene Labs

Dr Jianda Yuan, Director of Translational Immuno Oncology Research, Merck

Lei Zheng, Assistant Professor of Oncology, Johns Hopkins School of Medicine

Dr Daniel Zimmerman, Senior Vice President of Research, Cellular Immunology, CEL-SCI Corporation

Glen Zimmermann, Senior Director Business Development, West Pharmaceutical Services

Glen Zimmermann at World Vaccine Congress Washington 2017

 

 

 

 

Get involved

To exhibit, sponsor or speak at the event contact
Marc Rhys-Evans on +44 (0)20 7827 5945
or marc.rhys-evans@terrapinn.com